1. Gilead Sciences Inc. Harvoni® (ledipasvir and sofosbuvir) tablets for oral use: US prescribing information. 2015. http://www.harvoni.com/ . Accessed 30 Mar 2015.
2. European Medicines Agency. Harvoni (ledipasvir/sofosbuvir) film-coated tablets: EU summary of product characteristics. 2014. http://www.ema.europa.eu/ . Accessed 2 Mar 2015.
3. Hebner C, Lee Y-J, Han B, et al. In vitro pan-genotypic and combination activity of sofosbuvir (GS-7977) in stable replicon cell lines [abstract no. 1875]. Hepatology. 2012;56(4 Suppl):1066A.
4. Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370(20):1889–98.
5. Afdhal N, Reddy KR, Nelson DR, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014;370(16):1483–93.